SK23898A3 - Zwitterionic forms of trovafloxacin - Google Patents
Zwitterionic forms of trovafloxacin Download PDFInfo
- Publication number
- SK23898A3 SK23898A3 SK238-98A SK23898A SK23898A3 SK 23898 A3 SK23898 A3 SK 23898A3 SK 23898 A SK23898 A SK 23898A SK 23898 A3 SK23898 A3 SK 23898A3
- Authority
- SK
- Slovakia
- Prior art keywords
- trovafloxacin
- hygroscopic
- crystalline form
- zwitterionic
- polymorphic
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Physical Water Treatments (AREA)
- Processing Of Solid Wastes (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US297595P | 1995-08-29 | 1995-08-29 | |
| PCT/IB1996/000756 WO1997007800A1 (en) | 1995-08-29 | 1996-07-29 | Zwitterionic forms of trovafloxacin |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SK23898A3 true SK23898A3 (en) | 1999-05-07 |
Family
ID=21703460
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SK238-98A SK23898A3 (en) | 1995-08-29 | 1996-07-29 | Zwitterionic forms of trovafloxacin |
Country Status (30)
| Country | Link |
|---|---|
| EP (1) | EP0850060A1 (es) |
| JP (1) | JP3188476B2 (es) |
| KR (1) | KR100343909B1 (es) |
| CN (1) | CN1190889A (es) |
| AP (1) | AP636A (es) |
| AR (1) | AR003985A1 (es) |
| AU (1) | AU704115B2 (es) |
| BR (1) | BR9609998A (es) |
| CA (1) | CA2229786C (es) |
| CO (1) | CO4480739A1 (es) |
| CZ (1) | CZ56698A3 (es) |
| DZ (1) | DZ2087A1 (es) |
| GT (1) | GT199600072A (es) |
| HR (1) | HRP960395B1 (es) |
| HU (1) | HUP9900170A3 (es) |
| IL (1) | IL122651A (es) |
| MA (1) | MA23966A1 (es) |
| MY (1) | MY113874A (es) |
| NO (1) | NO309814B1 (es) |
| NZ (1) | NZ312199A (es) |
| OA (1) | OA10669A (es) |
| PE (1) | PE12598A1 (es) |
| PL (1) | PL325170A1 (es) |
| RU (1) | RU2144921C1 (es) |
| SK (1) | SK23898A3 (es) |
| TN (1) | TNSN96109A1 (es) |
| TR (1) | TR199800339T1 (es) |
| WO (1) | WO1997007800A1 (es) |
| YU (1) | YU48396A (es) |
| ZA (1) | ZA967282B (es) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HN1998000106A (es) | 1997-08-01 | 1999-01-08 | Pfizer Prod Inc | Composiciones parenterales de alatroflaxacino |
| US7019142B2 (en) | 1998-01-16 | 2006-03-28 | Pfizer Inc. | Process for preparing naphthyridones and intermediates |
| PA8466701A1 (es) * | 1998-01-21 | 2000-09-29 | Pfizer Prod Inc | Comprimido de mesilato de trovafloxacino |
| US6114531A (en) * | 1998-07-28 | 2000-09-05 | Pfizer Inc. | Process for preparing quinolone and naphthyridone carboxylic acids |
| HN1999000141A (es) * | 1998-09-03 | 2000-06-19 | Pfizer Prod Inc | Procedimiento para preparar sales de trovafloxacina de adicion de acidos. |
| US6239141B1 (en) | 1999-06-04 | 2001-05-29 | Pfizer Inc. | Trovafloxacin oral suspensions |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5164402A (en) * | 1989-08-16 | 1992-11-17 | Pfizer Inc | Azabicyclo quinolone and naphthyridinone carboxylic acids |
-
1996
- 1996-07-29 WO PCT/IB1996/000756 patent/WO1997007800A1/en not_active Application Discontinuation
- 1996-07-29 HU HU9900170A patent/HUP9900170A3/hu unknown
- 1996-07-29 JP JP50343697A patent/JP3188476B2/ja not_active Expired - Fee Related
- 1996-07-29 SK SK238-98A patent/SK23898A3/sk unknown
- 1996-07-29 KR KR10-1998-0701468A patent/KR100343909B1/ko not_active IP Right Cessation
- 1996-07-29 NZ NZ312199A patent/NZ312199A/xx unknown
- 1996-07-29 BR BR9609998A patent/BR9609998A/pt unknown
- 1996-07-29 AU AU63676/96A patent/AU704115B2/en not_active Ceased
- 1996-07-29 PL PL96325170A patent/PL325170A1/xx unknown
- 1996-07-29 CN CN96195624A patent/CN1190889A/zh active Pending
- 1996-07-29 RU RU98103873/04A patent/RU2144921C1/ru not_active IP Right Cessation
- 1996-07-29 CZ CZ98566A patent/CZ56698A3/cs unknown
- 1996-07-29 EP EP96923020A patent/EP0850060A1/en not_active Withdrawn
- 1996-07-29 TR TR1998/00339T patent/TR199800339T1/xx unknown
- 1996-07-29 CA CA002229786A patent/CA2229786C/en not_active Expired - Fee Related
- 1996-07-29 IL IL12265196A patent/IL122651A/xx not_active IP Right Cessation
- 1996-08-23 GT GT199600072A patent/GT199600072A/es unknown
- 1996-08-26 PE PE1996000633A patent/PE12598A1/es not_active Application Discontinuation
- 1996-08-26 AR ARP960104121A patent/AR003985A1/es unknown
- 1996-08-28 TN TNTNSN96109A patent/TNSN96109A1/fr unknown
- 1996-08-28 MY MYPI96003579A patent/MY113874A/en unknown
- 1996-08-28 DZ DZ960131A patent/DZ2087A1/fr active
- 1996-08-28 MA MA24344A patent/MA23966A1/fr unknown
- 1996-08-28 YU YU48396A patent/YU48396A/sh unknown
- 1996-08-28 ZA ZA9607282A patent/ZA967282B/xx unknown
- 1996-08-29 CO CO96046149A patent/CO4480739A1/es unknown
- 1996-08-29 HR HR960395A patent/HRP960395B1/xx not_active IP Right Cessation
- 1996-08-29 AP APAP/P/1996/000853A patent/AP636A/en active
-
1998
- 1998-02-27 OA OA9800026A patent/OA10669A/en unknown
- 1998-02-27 NO NO980862A patent/NO309814B1/no not_active Application Discontinuation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HRP20010281A2 (en) | New crystalline form of omeprazole | |
| PL190869B1 (pl) | Sól sodowa omeprazolu, sposób jej wytwarzania, środek farmaceutyczny i zastosowanie soli sodowej omeprazolu | |
| US5763454A (en) | Crystal form of anhydrous 7-( 1α,5α,6α!-6-amino-3-azabicyclo 3.1.0!hex-3-yl)-6-fluoro-1-(2,4-difluorophenyl)-1,4-dihydro-4-oxo-1,8 naphthyridine-3-carboxylic acid, methanessulfonic acid salt | |
| SK10372001A3 (sk) | Draselná soľ (S)-omeprazolu | |
| EP0579681B1 (en) | Crystalline tiagabine hydrochloride monohydrate, its preparation and use | |
| SK23898A3 (en) | Zwitterionic forms of trovafloxacin | |
| JPH06504541A (ja) | ４−アミノ−３−アシルキノリン誘導体の塩およびその胃酸分泌抑制剤としての使用 | |
| US6066647A (en) | Zwitterionic forms of trovafloxacin | |
| SK281980B6 (sk) | Kryštallický (+)l-hydrogenvínan, spôsob jeho prípravy, farmaceutický prostriedok s jeho obsahom a jeho použitie | |
| EP0847400B1 (en) | Polymorphs of the prodrug 6-n-(l-ala-l-ala)-trovafloxacin | |
| EP0584588A1 (en) | Anti-ulcer composition containing imidazole derivative | |
| EP1314726A1 (en) | Novel ester or amide derivatives | |
| MXPA98001664A (es) | Formas zwitterionicas de trovafloxacina, procedimiento para su preparacion, composiciones que las contienen y uso de las mismas | |
| AP788A (en) | Novel crystal form of anhydrous 7-(1a, 5a, 6a)-6-Amino-3-Azabicyclo(3.1.0) hex-3-YI)-6-Fluoro-1-(2,4- Difluorophenyl)-1,4-Dihydro-4-Oxo-1, 8-Naphthyridine-3-Carboxylic Acid, Methanesulfonic acid salt. | |
| KR20200068667A (ko) | 고체 형태의 스테모스피로닌 및 이의 염 | |
| SI21064A2 (sl) | Amidni derivat amlodipina |